Background: People receiving in-center hemodialysis face a high risk for contracting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and experience poor outcomes. During the first wave of the coronavirus disease 2019 (COVID-19) pandemic in Ontario (between March and June 2020), it was unclear whether asymptomatic or presymptomatic cases were common and whether widespread testing of all dialysis patients and staff would identify cases earlier and prevent transmission. Ontario has a population of about 14.
View Article and Find Full Text PDFAppl Health Econ Health Policy
February 2020
Background: The Provincial Drug Reimbursement Program (PDRP) at Cancer Care Ontario (CCO) is responsible for monitoring actual and projected outpatient intravenous cancer drug spending in the province. We developed a hybrid forecasting approach combining automated time-series forecasting with expert-customizable input.
Objective: Our objectives were to provide a flexible tool in which to incorporate multiple forecasts and to improve the accuracy of the resulting forecast.
This article shares the experiences of one acute care hospital as it made a concerted effort through a corporate initiative to improve patient throughput and quality of care despite competing demands and constrained resources. Organizational structures and specialized resources were employed to collect, analyze and use data in order to improve flow and access to care. The successes and lessons learned from this corporate initiative are summarized and may provide useful insights.
View Article and Find Full Text PDF